Germline multi-gene hereditary cancer panel testing in an unselected endometrial cancer cohort. - PubMed - NCBI

Germline multi-gene hereditary cancer panel testing in an unselected endometrial cancer cohort. - PubMed - NCBI

Mod Pathol. 2016 Nov;29(11):1381-1389. doi: 10.1038/modpathol.2016.135. Epub 2016 Jul 22.

Germline multi-gene hereditary cancer panel testing in an unselected endometrial cancer cohort.

Ring KL1, Bruegl AS2, Allen BA3, Elkin EP3, Singh N3, Hartman AR3, Daniels MS1, Broaddus RR4.

Author information

Abstract

Hereditary endometrial carcinoma is associated with germline mutations in Lynch syndrome genes. The role of other cancer predisposition genes is unclear. We aimed to determine the prevalence of cancer predisposition gene mutations in an unselected endometrial carcinoma patient cohort. Mutations in 25 genes were identified using a next-generation sequencing-based panel applied in 381 endometrial carcinoma patients who had undergone tumor testing to screen for Lynch syndrome. Thirty-five patients (9.2%) had a deleterious mutation: 22 (5.8%) in Lynch syndrome genes (three MLH1, five MSH2, two EPCAM-MSH2, six MSH6, and six PMS2) and 13 (3.4%) in 10 non-Lynch syndrome genes (four CHEK2, one each in APC, ATM, BARD1, BRCA1, BRCA2, BRIP1, NBN, PTEN, and RAD51C). Of 21 patients with deleterious mutations in Lynch syndrome genes with tumor testing, 2 (9.5%) had tumor testing results suggestive of sporadic cancer. Of 12 patients with deleterious mutations in MSH6 and PMS2, 10 were diagnosed at age >50 and 8 did not have a family history of Lynch syndrome-associated cancers. Patients with deleterious mutations in non-Lynch syndrome genes were more likely to have serous tumor histology (23.1 vs 6.4%, P=0.02). The three patients with non-Lynch syndrome deleterious mutations and serous histology had mutations in BRCA2, BRIP1, and RAD51C. Current clinical criteria fail to identify a portion of actionable mutations in Lynch syndrome and other hereditary cancer syndromes. Performance characteristics of tumor testing are sufficiently robust to implement universal tumor testing to identify patients with Lynch syndrome. Germline multi-gene panel testing is feasible and informative, leading to the identification of additional actionable mutations.

PMID:

 

27443514

 

DOI:

 

10.1038/modpathol.2016.135

[PubMed - in process]

Public Health Genomics Knowledge Base (v1.2)

LYNCH SYNDROME

Last Updated: Nov 15, 2016

• Ohio Statewide Colon Cancer Initiative 
• Time is running out to get a free cancer screening
  R Murray, Dayton Daily News, November 14, 2016
• Cost-effectiveness of routine screening for Lynch syndrome in endometrial cancer patients up to 70years of age.
  Goverde Anne et al. Gynecologic oncology 2016 Oct
• Germline multi-gene hereditary cancer panel testing in an unselected endometrial cancer cohort.
  Ring Kari L, et al. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2016 11 (11) 1381-1389
• Prevalence of Lynch syndrome in unselected patients with endometrial or ovarian cancer.
  Kast Karin, et al. Archives of gynecology and obstetrics 2016 11 (6) 1299-1303
• NICE recommends all bowel cancer patients to be tested for Lynch Syndrome
  Bowel Cancer UK, October 22, 2016
• NICE recommends wider use of tests to detect cancer-causing genetic condition
  NICE, United Kingdom, Draft Guidance, October 21, 2016
• Educational and Psychosocial Support Needs in Lynch Syndrome: Implementation and Assessment of an Educational Workshop and Support Group.
  Corines Marina J et al. Journal of genetic counseling 2016 Oct
• Implementing Public Health Genomics in Your State: Resources from the CDC Office of Public Health Genomics
  Disease: Lynch syndrome|Breast Cancer|Ovarian Cancer; Type: Education; State: Multiple States
• Evaluation of a Population Based Approach to Familial Colorectal Cancer.
  Parfrey P S, et al. Clinical genetics 2016 10
• Exploring clinicians' attitudes about using aspirin for risk reduction in people with Lynch Syndrome with no personal diagnosis of colorectal cancer.
  Chen Yanni et al. Familial cancer 2016 Sep
• Genetic screening in young women diagnosed with endometrial cancer.
  Pecorino Basilio et al. Journal of gynecologic oncology 2016 Sep e4
• Endometrial carcinoma-related genetic factors: application to research and clinical practice in China.
  Zhou J Y, et al. BJOG : an international journal of obstetrics and gynaecology 2016 9 90-6
• MLH1 Ile219Val Polymorphism in Argentinean Families with Suspected Lynch Syndrome.
  Dominguez-Valentin Mev, et al. Frontiers in oncology 2016 0 189
• Mismatch repair gene mutation spectrum in the Swedish Lynch syndrome population.
  Lagerstedt-Robinson Kristina, et al. Oncology reports 2016 9

• CDC Information (3)
• CDC-Authored Pub (9)

• Human (60)
• Pathogen (0)

• Human (297)
• Pathogen (0)

• Human (134)
• Pathogen (0)

• Guidelines (17)
• Tier Table (11)
• Synthesis (30)

• Huamn (76)
• Pathogen (0)

Relevant Resources

• Genetics and Genomics Competencies Center (G2C2)
• NIH Genetic Testing Registry
• NIH MedGen Database
• Online Mendelian Inheritance in Man (OMIM)
• PharmGKB